loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Ranolazine

    Client Email Product
    Menu

    Ranolazine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 84Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21526 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ranolazine(UNII: A6IEZ5M406)
    (ranolazine - UNII:A6IEZ5M406)     		ranolazine500mg

    Inactive Ingredients

    Ingredient Name
    Cardinal Health
    carnauba wax(R12CBM0EIZ)
    cellulose, microcrystalline(OP1R32D61U)
    ferric oxide red(1K09F3G675)
    ferric oxide yellow(EX438O2MRT)
    HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4)
    hypromelloses(3NXW29V3WO)
    magnesium stearate(70097M6I30)
    methacrylic acid - Ethyl Acrylate Copolymer (1:1) Type A(NX76LV5T8J)
    polyethylene glycol 3350(G2M7P15E5P)
    polyethylene glycol 400(B697894SGQ)
    POLYVINYL ALCOHOL(532B59J990)
    sodium hydroxide(55X04QC32I)
    TALC(7SEV7J4R1U)
    titanium dioxide(15FIX9V2JP)
    water(059QF0KO0R)